Training Experience Required
Fluency in English is required. For a clinical fellowship understanding of Dutch is essential.
Please contact us to discuss specific training requirements for the project you are interested in.
General Description
Erasmus MC is the largest University Medical Center in the Netherlands, with core activities of excellent patient care, world-class education, and field-leading research. There are >12,000 employees (of which 1,300 researchers), 2,500 medical students, and each year ~200 PhD graduations. We wish to deliver a standard of healthcare as befits our status as an enterprising university medical center. This means that our focus is on treating and caring for patients with complex healthcare issues, rare disorders, and complex, acute care needs. We are an academic powerhouse shaping, leading, and facilitating new regional, national, and international partnerships and networks, and connecting the Rotterdam region with new developments in the Netherlands and further afield. Our aim is to be a driving force strengthening and enriching existing partnerships and challenging our partners to seek the unexpected. We will make the most of the synergy and innovations resulting from these partnerships to promote a healthy society and thus make a social impact. Innovation has always been an essential part of our work. We aim to lead the way and stand out from the field in our use of technology for shaping healthcare in the future. Our ambition is to be the first technical university medical center in the Netherlands. As a result of the explosion in the opportunities offered by technology and digital in health monitoring, teaching, and research, combined with the pressure placed on the healthcare system in terms of staffing and solidarity, both healthcare and hospitals will look fundamentally different in the future. Technology and data analysis will produce innovative solutions to biomedical and medical problems and bridge the gap between the medical faculty and the academic hospital. Data-yielding technologies will ensure that fundamental and translational research will become clinically relevant much more quickly than in the past and also that we acquire new insights from clinical data more quickly than we used to. The 'medical humanities' will play a vital role in the development and use of technology and the use of data in healthcare. It will be vital to strike the right balance between people (i.e. healthy citizens, patients, doctors, and students) and machines.
Expertise
Within the department of Pulmonary Medicine, the Thoracic Oncology Research group is specialized in optimisation of current treatments and development of new treatments for thoracic cancers, with a strong focus on immuno-oncology, targeted therapy and neuro-endocrine tumors of the lung. The research of the department covers the full range from fundamental research and translational research to clinical research.
Currently, ~100 clinical trials, from phase I to phase III, are ongoing at our department, facilitated and executed by the departments' dedicated research bureau. The department of pulmonary medicine is a tertiary referral center for lung cancer and mesothelioma and a national and international known immune-oncology center. The department of Pulmonary Medicine is acknowledged by the Dutch Federation of Universities as center of expertise on multiple (rare) diseases, among which rare thoracic cancers and interstitial lung diseases. The department is represented in the European Reference Network on Rare Respiratory Diseases (ERN-LUNG); prof. dr. Joachim Aerts is coordinator of the core network on mesothelioma, and four staff members are participating in four other core networks. Prof. dr. Anne-Marie Dingemans is lead author of the ESMO-SCLC guideline and chair of the EORTC-lung cancer group.
Facilitites
Our expertise in these tumor types also encompasses the use of immunotherapy, chemotherapy, targeted therapy, surgery and radiation. The department of pulmonary medicine has a large laboratory for basic and translational research. Erasmus MC has core facilities with support personnel include a central animal facility (mice, rat, rabbits and pigs), central imaging facilities for live animals with 7T MRI, micro-CT, Bioluminescence Imaging, PET-SPECT. A central biomics facility, Optical Imaging Center, GMP facility and iPS facility. Erasmus MC has recently acquired a SOMAscan protein identification device. It is the only device of its' kind in Europe. This unique device allows the analysis of thousands of proteins simultaneously. The Erasmus MC is fully equipped to perform clinical early phase studies. To perform the preclinical analysis a laboratory is available which is equipped with all state of the art equipment and a close collaboration is present with the different departments in Erasmus MC. Erasmus MC has a longstanding record in haematological dieases and is experienced in cell-based therapy. Recently the department was fully certificated according to EU guidelines to perform cell-based therapy.
Last update: September 2021
